{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:30:48Z","timestamp":1792783848301,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Region Wallonne","award":["TEMOEX-PAND 1217668"],"award-info":[{"award-number":["TEMOEX-PAND 1217668"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.clinbiochem.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T02:03:59Z","timestamp":1424484239000},"page":"542-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Validation of a HPLC-MS\/MS assay for the determination of total and unbound concentration of temocillin in human serum"],"prefix":"10.1016","volume":"48","author":[{"given":"Perrin","family":"Ngougni Pokem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Miranda Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Tulkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wallemacq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-7991","authenticated-orcid":false,"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Capron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/AAC.22.3.453","article-title":"Antibacterial activity and beta-lactamase stability of temocillin","volume":"22","author":"Jules","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkn511","article-title":"Temocillin revived","volume":"63","author":"Livermore","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0015","unstructured":"Temocillin Summary of Product Characteristics. UK Medicines and Health-care products Regulatory Agency (MHRA) 12A.D."},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","author":"Craig","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0025","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jac\/dku465","article-title":"Temocillin 6g daily in critically-ill patients: continuous infusion versus thrice daily administration","volume":"70","author":"Laterre","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0030","series-title":"ESCMID (European Society of Clinical Microbiology and Infectious Diseases) conference on reviving old antibiotics, Vienna, Austria 2014;P26","article-title":"Clinical pharmacokinetics of temocillin in patients with end stage renal disease undergoing haemodialysis","author":"Miranda Bastos","year":"2014"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0035","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10337-014-2741-6","article-title":"Analysis of temocillin and impurities by reversed phase liquid chromatography: development and validation of the method","volume":"77","author":"Kahsay","year":"2014","journal-title":"Chromatographia"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpba.2013.12.002","article-title":"Development and validation of a high performance liquid chromatography assay for the determination of temocillin in serum of haemodialysis patients","volume":"90","author":"Miranda Bastos","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jac\/dkm467","article-title":"Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection","volume":"61","author":"De Jongh","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0050","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1542\/peds.2007-0630","article-title":"Stability of antibiotics in portable pumps used for bronchial superinfection: guidelines for prescribers","volume":"120","author":"Arlicot","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0055","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/jac\/dkq229","article-title":"Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients","volume":"65","author":"Carryn","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0060","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1345\/aph.1A150","article-title":"Stability of piperacillin and ticarcillin in AutoDose infusion system bags","volume":"35","author":"Zhang","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0065","series-title":"Bioanalytical method validation, U.S. Department of Health and Human Services","author":"Guidance for Industry","year":"2011"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2015.02.006_bb0075","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00216-012-6636-9","article-title":"A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients","volume":"405","author":"Boelaert","year":"2013","journal-title":"Anal Bioanal Chem"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:46:01Z","timestamp":1757864761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":15,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0009912015000600"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.02.006","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a HPLC-MS\/MS assay for the determination of total and unbound concentration of temocillin in human serum","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}